Orchid, Struggling to Escape Delisting, Plans to Appeal Nasdaq Decision

genomeweb
360dx

Orchid, Struggling to Escape Delisting, Plans to Appeal Nasdaq Decision

Jan 13, 2003

NEW YORK, Jan. 13-Orchid Biosciences has received a delisting warning notice from Nasdaq, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Large Study Uncovers Genetic Connections Between Numerous Psychiatric Disorders
Cigna to Cover GenomeDx's Decipher Prostate Cancer Tests
Nightingale, UK Biobank to Analyze Metabolomic Markers in 500K Blood Samples
FDA Clears DiaSorin HSV Assay for Extended Swab Sample Claims
Namocell Signs Distribution Deal for Single-Cell Dispenser in Japan
Genedrive Receives UK NIHR Grant for Antibiotic-Related Hearing Loss Assay

The Scan

DNA Tests Considered to Verify Relatedness at Border

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

First of 'Right to Try'

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

This Week in Nature

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

How Old Were They?

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Main menu